Viewing Study NCT06757335


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2025-12-25 @ 7:55 PM
Study NCT ID: NCT06757335
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-03
First Post: 2024-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer
Sponsor: Hinova Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module